siRNA, Anti-SLC38A4, 2'-F/2'-OMe/LNA/Ribo/Backbone-modified(CAT#: SIRGT41522WQ-2OMe)

The product SIRGT41522WQ-2OMe is a type of small interfering RNA (siRNA) that targets SLC38A4 gene and regulates the expression of gene. The siRNA interferes with the expression of SLC38A4 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001143824.1
Alternative Names ATA3; NAT3; PAAT; SNAT4
Related Diseases Loeys-Dietz Syndrome
Purification HPLC
Target Gene
Gene ID 55089
Uniprot ID Q969I6
Sub Cat Target Species Modification Scale  
SIRGT42522WQ-2F SLC38A4 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT44522WQ-LNA SLC38A4 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT41522WQ-RB SLC38A4 Human Ribo-modified Inquiry
SIRGT42522WQ-BB SLC38A4 Human Backbone-modified Inquiry

Related Products